David H Aggen, MD PhD
@dr_aggen
Assistant Attending, MSKCC, Genitourinary Oncology Service
Tweets are my own opinions and do not represent the views or opinions of Memorial Sloan Kettering
ID: 728682616271065090
06-05-2016 20:27:28
1,1K Tweet
621 Takipçi
268 Takip Edilen
We are actively enrolling patients with high risk bladder cancer on a trial evaluating a personalized mRNA neoantigen vaccine, autogene cevumeran, with immunotherapy following bladder surgery. Memorial Sloan Kettering Cancer Center #bladdercancer clinicaltrials.gov/study/NCT06534… mskcc.org/cancer-care/cl…